International journal of radiation oncology, biology, physics · 2026
Comparison of Computed Tomography Ventilation Imaging and Hyperpolarized 3He Magnetic Resonance Imaging in Patients With Lung Cancer.
СтатьяСравнительное исследованиеРандомизированное исследованиеКлиническое исследование II фазыПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ito Shinya, Nakajima Yujiro, Fujita Yukio, Capaldi Dante P I, Sheikh Khadija, Parraga Grace, Kabus Sven, Palma David A, Yaremko Brian, Hoover Douglas, Yamamoto Tokihiro
Аннотация
PURPOSE: Computed tomography ventilation imaging (CTVI) has great potential for clinical translation and has been validated in numerous studies. However, previous studies focused on image comparisons, and little is known about the dosimetric implications of "good" or "poor" image correlations or agreements in radiation therapy (RT). This study assessed the agreement of dose-function metrics between CTVI and hyperpolarized 3He magnetic resonance imaging (MRI) as a reference.
METHODS AND MATERIALS: This study included 27 patients with non-small cell lung cancer who were randomized in a phase 2 trial examining 3He MRI-guided functional avoidance RT. All patients underwent 4-dimensional computed tomography and 3He MRI. CTVI was retrospectively created. Pearson correlation and Bland-Altman analyses were performed to assess the agreements between 3He MRI- and CTVI-based well-ventilated lung dose-function metrics, including functional V20Gy (fV20Gy) and functional mean lung dose, of RT plans. To assess the associations between dose-function metrics and clinical outcomes, we dichotomized patients by a clinically meaningful decline in Functional Assessment of Cancer Therapy-Lung: Lung Cancer Subscale (≥3-point) and the occurrence of grade ≥2 radiation pneumonitis and compared the dose-function metrics between the 2 groups.
RESULTS: Correlation coefficients of dose-function metrics were 0.80 to 0.82 for both fV20Gy and functional mean lung dose. Bland-Altman analyses showed a mean difference < 1% for fV20Gy, with 95% limits of agreement of 8% to 10%, indicating that agreements varied among patients. Among Lung Cancer Subscale-evaluable patients (n = 20), those with a ≥3-point decline (n = 8) had higher fV20Gy than those without (CTVI: 28.2% vs 21.9%, P = .05; 3He MRI: 26.2% vs 22.3%, P = 0.24). Patients with grade ≥2 radiation pneumonitis (n = 4) also showed higher values than those without (CTVI: 28.2% vs 24.2%, P = .34; 3He MRI: 27.0% vs 23.5%, P = .25).
CONCLUSIONS: CTVI demonstrated strong correlations and small bias in dose-function metrics with 3He MRI, including fV20Gy and functional mean lung dose. These findings support CTVI as a ventilation surrogate for functional avoidance RT.
METHODS AND MATERIALS: This study included 27 patients with non-small cell lung cancer who were randomized in a phase 2 trial examining 3He MRI-guided functional avoidance RT. All patients underwent 4-dimensional computed tomography and 3He MRI. CTVI was retrospectively created. Pearson correlation and Bland-Altman analyses were performed to assess the agreements between 3He MRI- and CTVI-based well-ventilated lung dose-function metrics, including functional V20Gy (fV20Gy) and functional mean lung dose, of RT plans. To assess the associations between dose-function metrics and clinical outcomes, we dichotomized patients by a clinically meaningful decline in Functional Assessment of Cancer Therapy-Lung: Lung Cancer Subscale (≥3-point) and the occurrence of grade ≥2 radiation pneumonitis and compared the dose-function metrics between the 2 groups.
RESULTS: Correlation coefficients of dose-function metrics were 0.80 to 0.82 for both fV20Gy and functional mean lung dose. Bland-Altman analyses showed a mean difference < 1% for fV20Gy, with 95% limits of agreement of 8% to 10%, indicating that agreements varied among patients. Among Lung Cancer Subscale-evaluable patients (n = 20), those with a ≥3-point decline (n = 8) had higher fV20Gy than those without (CTVI: 28.2% vs 21.9%, P = .05; 3He MRI: 26.2% vs 22.3%, P = 0.24). Patients with grade ≥2 radiation pneumonitis (n = 4) also showed higher values than those without (CTVI: 28.2% vs 24.2%, P = .34; 3He MRI: 27.0% vs 23.5%, P = .25).
CONCLUSIONS: CTVI demonstrated strong correlations and small bias in dose-function metrics with 3He MRI, including fV20Gy and functional mean lung dose. These findings support CTVI as a ventilation surrogate for functional avoidance RT.